Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A1EWVY8
Mon, 29.01.2024
Formycon AG
Press Release // January 29, 2024
Gedeon Richter becomes strategic investor of Formycon via equity investment
Already established trustful collaboration in contract development and manufacturing results in investment through takeover of 9.08% of shares via cash capital increase
Gross-proceeds in the amount of EUR 82.84 million to maintain Formyc [ … ]
Thu, 18.01.2024
Formycon AG
Press Release // January 18, 2024
Formycon Ranibizumab Biosimilar FYB201/CIMERLI® achieved a market share of 38% in the United States in December 2023
Munich, Germany – Formycon AG (FWB: FYB) today announced that its commercialization partner, Coherus BioSciences, Inc. has released new sales figures for CIMERLI®1 (Ranibizumab-eqrn) in the US [ … ]
Thu, 04.01.2024
Formycon AG
Press Release // January 04, 2024
Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference
Munich, Germany – Formycon AG (FSE: FYB), a leading, independent developer of high-quality biosimilars, today announced that Formycon CEO Dr. Stefan Glombitza will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference on T [ … ]